Market revenue in 2023 | USD 5.9 million |
Market revenue in 2030 | USD 11.9 million |
Growth rate | 10.7% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 52.54% in 2023. Horizon Databook has segmented the Latin America deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Major countries contributing to the growth of Latin America deep brain stimulation devices market are Brazil and Mexico. Growing healthcare expenditure coupled with rising penetration of health insurance in most of the Latin American countries is providing considerable growth opportunities to players operating in the global market.
Moreover, several health agreements exist between U.S. medical centers and private hospitals in Brazil and Argentina. These agreements have increased awareness about new technologies in the market, boosting the adoption of deep brain stimulation systems.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account